Xencor (XNCR) Revenue (2013 - 2026)
Xencor (XNCR) posted quarterly Revenue of $4.5 million for Q1 2026, down 86.2% year-over-year from $32.7 million in Q1 2025, and down 84.01% quarter-over-quarter from $28.2 million in Q4 2025.
Analysis
Xencor (XNCR) Revenue (2013 - 2026) Analysis & Trends
Xencor (XNCR) has reported Revenue for 14 consecutive years, with $4.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue fell 86.2% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $97.4 million (down 23.48% YoY), while the FY2025 annual figure was $125.6 million, up 13.65% from the prior year.
- Revenue retreated to $4.5 million in Q1 2026 per XNCR's latest filing, from $28.2 million in the prior quarter.
- Across five years, Revenue topped out at $85.5 million in Q1 2022 and bottomed at $4.5 million in Q1 2026.
- Historically, Revenue has averaged $34.1 million across 5 years, with a median of $28.2 million in 2025.
- Annual changes were most pronounced in 2022 — Revenue jumped 151.46% — and 2026, when it sank 86.2%.
- Xencor's Revenue stood at $21.6 million in 2022, then jumped by 136.07% to $51.0 million in 2023, then grew by 3.49% to $52.8 million in 2024, then tumbled by 46.51% to $28.2 million in 2025, then sank by 84.01% to $4.5 million in 2026.
- Business Quant data shows XNCR's Revenue at $4.5 million in Q1 2026, $28.2 million in Q4 2025, and $21.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Xencor | 2.01 Bn | 1.64 Bn | - | 51.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.22 Mn |
| Mar 31, 2026 | 4.52 Mn |
| Dec 31, 2025 | 28.24 Mn |
| Sep 30, 2025 | 21.00 Mn |
| Jun 30, 2025 | 43.61 Mn |
| Mar 31, 2025 | 32.73 Mn |
| Dec 31, 2024 | 52.79 Mn |
| Sep 30, 2024 | 17.80 Mn |
| Jun 30, 2024 | 23.91 Mn |
| Mar 31, 2024 | 16.00 Mn |
| Dec 31, 2023 | 50.97 Mn |
| Sep 30, 2023 | 59.20 Mn |
| Jun 30, 2023 | 45.52 Mn |
| Mar 31, 2023 | 19.00 Mn |
| Dec 31, 2022 | 21.60 Mn |
| Sep 30, 2022 | 27.30 Mn |
| Jun 30, 2022 | 30.20 Mn |
| Mar 31, 2022 | 85.50 Mn |
| Dec 31, 2021 | 154.01 Mn |
| Sep 30, 2021 | 19.70 Mn |